Search Orphan Drug Designations and Approvals
-
Generic Name: | [(4-benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone]-phosphate |
---|---|
Date Designated: | 08/07/2018 |
Orphan Designation: | Treatment of Angelman Syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Seneca Biopharma, Inc. 20271 Goldenrod Lane Suite 2024 Germantown, Maryland 20876 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-